http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
Entourage Health Announces Preliminary Record Q2 Revenues of $13.6 Million and Confirms Financial Results Call to be Held on August 10, 2021 at 10 a.m. ET
-
Entourage Health Announces Debut of New Ticker “ENTG” on TSX Venture
-
WeedMD Inc. and CannTx Life Sciences Sign Definitive Acquisition Agreement and Confirm Corporate Name as Entourage Health Corp.
-
WeedMD Inc. Announces Intent to Change Corporate Name to Entourage Health Corp.
-
WeedMD Reports First Quarter 2021 Financial Results with 102% Record Increase in Sequential Net Revenue Growth
-
WeedMD Expands its Color Cannabis Brand into the Province of New Brunswick
-
WeedMD Sells Fully Licensed Bowmanville Operating Assets
-
WeedMD and Privately Owned CannTx Life Sciences Sign Letter of Intent to Create a Cannabis Cultivation and Consumer-Centric Product Portfolio
-
WeedMD Reports Fiscal Year 2020 Financial Results and First Quarter 2021 Preliminary Gross Revenue of $12 Million
-
WeedMD to Host Fiscal Year End 2020 Conference Call on May 31st
-
WeedMD Launches New Product Collaboration with CannTx Life Sciences for Release of Limited Edition Cultivars to Starseed Medicinal
-
WeedMD Management to Present at Canaccord Genuity’s Annual Global Cannabis Virtual Conference on May 11th
-
WeedMD Announces Participation in Upcoming Investor Events
-
WeedMD Appoints Dynamic Leader Beth Carreon as New Chief Financial Officer
-
WeedMD to Host Fiscal Year-End 2020 Conference Call on April 30, 2021
-
WeedMD Added to Horizons Marijuana Life Sciences Index ETF
-
WeedMD Announces Supplemental Listing of Warrants
-
WeedMD’s Color Cannabis Expands Product Portfolio with Debut of Live Resin in Pedro’s Sweet Sativa Cultivar
-
WeedMD Announces Closing of $17.25 Million Bought Deal Offering
-
WeedMD Files Amended Third Quarter 2020 Interim Financial Statements
-
WeedMD’s Starseed Medicinal Announces the Release of Strain-Specific Products for PAX® ERA® Vaporizer
-
WeedMD Announces Mary’s Medicinals Topicals Product Release in Canada
-
WeedMD’s Saturday Cannabis Vaporizers Debut as the Top Seller in Ontario and Color Cannabis Brand Launches 15 gram Dried Flower Products
-
WeedMD confirme que ses produits de Color Cannabis sont disponibles au Québec
-
WeedMD’s Starseed Medicinal Signs Sixth LiUNA Local to Medical Cannabis Program and Expands Coverage to Manitoba
-
WeedMD Announces the Development of New Cannabis 2.0 Products Featuring Hash, Live Resin and Rosin Extracts for Adult-Use Lineup
-
WeedMD Expands its Color Cannabis Brand into the Province of Quebec
-
WeedMD Consolidates Medical Distribution Activities and Closes Facility to Maximize Production Efficiencies
-
WeedMD Posts New Year Shareholder Newsletter From Interim CEO
-
WeedMD Announces CEO Leadership Transition and New Board Appointment
-
WeedMD Launches Terpene-Infused Saturday Cannabis-branded Vaporization Products
-
WeedMD’s Color Cannabis Brand Selected as Top Sativa Flower for “Pedro’s Sweet Sativa” at Inaugural Kind Magazine Awards
-
WeedMD Debuts New Color Cannabis Cultivar Black Sugar Rose in Ontario and Launches Terpene-Labelled Profiles
-
WeedMD Reports Third Quarter 2020 Financial Results
-
WeedMD Expands Starseed Medicinal Access to Atlantic Canada Alongside Leading Cannabis Physician and Advocate Dr. Julie Hildebrand
-
WeedMD Schedules Third Quarter 2020 Conference Call for December 1st, 2020
-
WeedMD’s Color Cannabis Vaporizers Make Strong Entry in Ontario
-
WeedMD Issues Deferred Share Units
-
WeedMD Appoints Seasoned HR Executive to Chief People Officer
-
WeedMD Appoints Veteran Finance Executive to its Board of Directors
-
WeedMD Announces Cannabis 2.0 Supply Partnership with PAX LABS®
-
WeedMD to Participate in the Jefferies Virtual Cannabis Summit 2020
-
WeedMD Reports Second Quarter 2020 Financial Results and Closes $30 Million Credit Facility with LiUNA Pension Fund
-
WeedMD Closes Definitive Agreement for $30 Million Credit Facility with LiUNA Pension Fund
-
WeedMD Enters into Binding Term Sheet for $30 Million Credit Facility with LiUNA Pension Fund and Changes Filing Date of Second Quarter 2020 Financials to September 30, 2020
-
WeedMD and Starseed Medicinal Launch Combined Medical Sales Marketplace with Expanded Cannabis Product Offerings
-
WeedMD Secures Expanded Health Canada Licence to Sell All Cannabis Formats from Flagship Cultivation Facility
-
WeedMD Advances Strategic Growth Initiatives in the Adult-Use Market with New Color Cannabis Offerings
-
WeedMD Announces Investor Conference Presentations in September
-
WeedMD to File Second Quarter 2020 Financials on September 23rd

